Evidence map›Paper›PMID 28930537›Full record

ReviewFrontiers in bioscience (Landmark edition)2018

Differences in ion channel phenotype and function between humans and animal models.

Mark R Tanner, Christine Beeton

Abstract readReview
In one paragraph

Review in Frontiers in bioscience (Landmark edition), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Rett Syndrome: Thinking Beyond Brain Borders.Advances in experimental medicine and biology · 2025
    Review
  11. Article
  12. Review
  13. Review
  14. Interspecies and regional variability of alcohol action on large cerebral arteries: regulation by KCNMB1 proteins.American journal of physiology. Regulatory, integrative and comparative physiology · 2023
    Article
  15. Article
  16. Article
  17. Modeling the human heart ex vivo-current possibilities and strive for future applications.Journal of tissue engineering and regenerative medicine · 2022
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Mark R TannerDepartment of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston TX 77030, and Interdepartmental Graduate Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston TX 77030.
Christine BeetonDepartment of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston TX 77030, and Center for Drug Discovery and Biology of Inflammation Center, Baylor College of Medicine, Houston TX 77030, beeton@bcm.edu.
Baylor College of Medicine · US

Funding

Immunology Scientist Training ProgramT32AI053831 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI CORRY, DAVID B · 2003 to 2018
$4.2M
Training Program in Translational Biology and Molecular MedicineT32GM088129 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI ROONEY, CLIONA M., VAN DEN VEYVER, IGNATIA B · 2010 to 2019
$3.0M
New Peptides for the Treatment of Multiple SclerosisR01NS073712 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI BEETON, CHRISTINE · 2011 to 2015
$1.8M
Regulation of cellular interactions by potassium channels in RAF31AR069960 · NIAMS · BAYLOR COLLEGE OF MEDICINE · PI TANNER, MARK R · 2016 to 2017
$76k
NIAID NIH HHS T32 AI053831NIAMS NIH HHS F31 AR069960NIGMS NIH HHS T32 GM088129NINDS NIH HHS R01 NS073712
6 · The paper itself

Abstract

Ion channels play crucial roles in regulating a broad range of physiological processes. They form a very large family of transmembrane proteins. Their diversity results from not only a large number of different genes encoding for ion channel subunits but also the ability of subunits to assemble into homo- or heteromultimers, the existence of splice variants, and the expression of different regulatory subunits. These characteristics and the existence of very selective modulators make ion channels very attractive targets for therapy in a wide variety of pathologies. Some ion channels are already being targeted in the clinic while many more are being evaluated as novel drug targets in both clinical and preclinical studies. Advancing ion channel modulators from the bench to the clinic requires their assessment for safety and efficacy in animal models. While extrapolating results from one species to another is tempting, doing such without careful evaluation of the ion channels in different species presents a risk as the translation is not always straightforward. Here, we discuss differences between species in terms of ion channels expressed in selected tissues, differing roles of ion channels in some cell types, variable response to pharmacological agents, and human channelopathies that cannot fully be replicated in animal models.

Indexed as

Gene Expression ProfilingMutationAnimalsCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDisease Models, AnimalGenetic Predisposition to DiseaseHumansIon ChannelsPhenotypeCystic Fibrosis Transmembrane Conductance RegulatorIon Channels

Identifiers

PMID28930537
PMCPMC5626566
OpenAlexW2759906622

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.